» Articles » PMID: 28291782

Obesity Paradox in Stroke - Myth or Reality? A Systematic Review

Overview
Journal PLoS One
Date 2017 Mar 15
PMID 28291782
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Both stroke and obesity show an increasing incidence worldwide. While obesity is an established risk factor for stroke, its influence on outcome in ischemic stroke is less clear. Many studies suggest a better prognosis in obese patients after stroke ("obesity paradox"). This review aims at assessing the clinical outcomes of obese patients after stroke by performing a systematic literature search.

Methods: The reviewers searched MEDLINE from inception to December 2015. Studies were eligible if they included outcome comparisons in stroke patients with allocation to body weight.

Results: Twenty-five studies (299'750 patients) were included and none was randomised. Ten of 12 studies (162'921 patients) reported significantly less mortality rates in stroke patients with higher BMI values. Seven of 9 studies (92'718 patients) ascertained a favorable effect of excess body weight on non-fatal outcomes (good clinical outcome, recurrence of vascular events). Six studies (85'042 patients) indicated contradictory results after intravenous thrombolysis (IVT), however. Several methodological limitations were observed in major part of studies (observational study design, inaccuracy of BMI in reflecting obesity, lacking body weight measurement, selection bias, survival bias).

Conclusion: Most observational data indicate a survival benefit of obese patients after stroke, but a number of methodological concerns exist. No obesity paradox was observed in patients after IVT. There is a need for well-designed randomized controlled trials assessing the effects of weight reduction on stroke risk in obese patients.

Citing Articles

Exploring Nontraumatic Brain Hemorrhage in Sudden and Unexpected Deaths: A Novel Autopsy-Based Investigation.

Kanani J, Sheikh M Asian J Neurosurg. 2025; 20(1):126-131.

PMID: 40041594 PMC: 11875705. DOI: 10.1055/s-0044-1800811.


Nutritional interventions to prevent and reduce overweight and obesity during postacute stroke rehabilitation: a scoping review protocol.

Nortoft M, Sorensen D, Aadal L BMJ Open. 2025; 15(2):e092156.

PMID: 39915013 PMC: 11831313. DOI: 10.1136/bmjopen-2024-092156.


Lean body mass and stroke volume, a sex issue.

Delsaut B, Abderrakib A, Ligot N, Naeije G Front Neurol. 2025; 15:1443356.

PMID: 39911742 PMC: 11794084. DOI: 10.3389/fneur.2024.1443356.


Exploring the Obesity Paradox in All Subtypes of Intracranial Hemorrhage: A Retrospective Cohort Analysis of 13,000 Patients.

Ng H, Huhulea E, Jain A, Fortunato M, Subah G, Sacknovitz A Brain Sci. 2025; 14(12.

PMID: 39766399 PMC: 11675038. DOI: 10.3390/brainsci14121200.


Joint association of triglyceride glucose index (TyG) and a body shape index (ABSI) with stroke incidence: a nationwide prospective cohort study.

Zhang R, Hong J, Wu Y, Lin L, Chen S, Xiao Y Cardiovasc Diabetol. 2025; 24(1):7.

PMID: 39762919 PMC: 11705842. DOI: 10.1186/s12933-024-02569-5.


References
1.
Stein P, Beemath A, Olson R . Obesity as a risk factor in venous thromboembolism. Am J Med. 2005; 118(9):978-80. DOI: 10.1016/j.amjmed.2005.03.012. View

2.
Amundson D, Djurkovic S, Matwiyoff G . The obesity paradox. Crit Care Clin. 2010; 26(4):583-96. DOI: 10.1016/j.ccc.2010.06.004. View

3.
Steinberg B, Cannon C, Hernandez A, Pan W, Peterson E, Fonarow G . Medical therapies and invasive treatments for coronary artery disease by body mass: the "obesity paradox" in the Get With The Guidelines database. Am J Cardiol. 2007; 100(9):1331-5. DOI: 10.1016/j.amjcard.2007.06.019. View

4.
Hu G, Tuomilehto J, Silventoinen K, Sarti C, Mannisto S, Jousilahti P . Body mass index, waist circumference, and waist-hip ratio on the risk of total and type-specific stroke. Arch Intern Med. 2007; 167(13):1420-7. DOI: 10.1001/archinte.167.13.1420. View

5.
Hubert H, Feinleib M, MCNAMARA P, CASTELLI W . Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983; 67(5):968-77. DOI: 10.1161/01.cir.67.5.968. View